White Papers
Digital therapeutics startups, payers, and other stakeholders are getting on board for transforming the treatment standards. Nowadays, digital therapeutics has expanded its horizons to evidence-based wellness, chronic diseases such as diabetes, and sleep disorder apps. For digital therapeutics companies investing in novel products, the lack of public health insurance coverage is a major limiting factor.